Conformational dynamics of 4-aryl-1,4-dihydropyridine calcium channel antagonists. 1. Quantitation of C4-C1' bond rotational barriers

Tetrahedron

Volumn 52, Issue 29, 1996, Pages 9665-9680

  Palmer, Robert B ^a   Andersen, Niels H ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 DIHYDRO 2,6 DIMETHYL 4 (2' CHLORO 6' METHYLPHENYL) 3,5 PYRIDINE DICARBOXYLIC ACID DIMETHYL ESTER; 1,4 DIHYDROPYRIDINE DERIVATIVE; CALCIUM CHANNEL; CALCIUM CHANNEL BLOCKING AGENT; NIFEDIPINE; UNCLASSIFIED DRUG;

ANGINA PECTORIS; ANTIHYPERTENSIVE THERAPY; ARTICLE; CRYSTAL STRUCTURE; DRUG CONFORMATION; DRUG STRUCTURE; DRUG SYNTHESIS; HYPERTENSION; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TEMPERATURE DEPENDENCE; THERMODYNAMICS; X RAY CRYSTALLOGRAPHY;

EID: 0030586114     PISSN: 00404020     EISSN: None     Source Type: Journal    
DOI: 10.1016/0040-4020(96)00500-5     Document Type: Article

References (29)

1. 1 Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th edition; Gilman, A. G.; Rall, T. W.; Nies, A. S.; Taylor, P., Eds.; Pergamon Press, Inc.: Elmsford, New York, 1990; p 774.
2. 2 Loev, B.; Goodman, M. M.; Snader, K. M.; Tedeschi, R.; Macko, E. J. Med. Chem. 1974, 17, 956.
3. 3 Rodenkirchen, R.; Bayer, R.; Steiner, R.; Bossert, F.; Meyer, H.; Moller, E. Arch. Pharm. (Weinheim, Ger.) 1979, 310, 69.
4. 4 Janis, R. A.; Triggle, D. J. J. Med. Chem. 1983, 26, 775.
5. 5 Miyamae, A.; Koda, S.; Morimoto, Y. Chem. Pharm. Bull. 1986, 34, 3071.
6. 6 Mahmoudian, M.; Richards, W. G.; J. Chem. Soc., Chem. Commun. 1986, 739.
7. 7 Berntsson, P.; Carter, R. E. Acta Pharm. Suec. 1981, 18, 221.
8. 8 Gaggelli, E.; Marchettini, N.; Valensin, G. J. Chem. Soc. Perkin Trans. II 1987, 1707.
9. 9 Triggle, A.M.; Shefter, E.; Triggle, D. J. J. Med. Chem. 1980, 23, 1442.
10. 10 Fossheim, R.; Svarteng, K.; Mostad, A.; Romming, C.; Shefter, E.; Triggle, D. J. J. Med. Chem. 1982, 25, 126.
11. 11 Fossheim, R. Acta Chem. Scand. 1985, 39, 785.
12. 12 Fossheim, R. Acta Chem. Scand. 1986, 40, 776.
13. 13 Fonesca, I.; Martinez-Carrera, S.; Garcia-Blanco, S.; Acta Crystallogr., Sect C: Crystal Struct. Commun. 1986, C42, 1792.
14. 14 Rovnyak, G.; Andersen, N.; Gougoutas, J.; Hedberg, A.; Kimball, S. D.; Malley, M.; Moreland, S.; Porubcan, M.; Pudzianowski, A. J. Med. Chem. 1988, 31, 936.
15. 15 Holtje, H. D.; Marrar, S. J. J. Comput. Aided Mol. Des. 1987, 1, 23.
16. 16 Tury Nagy, L; Jergolova, M. Chem. Papers 1989, 43, 279.
17. 17 Rovnyak, G.; Andersen, N.; Gougoutas, J.; Hedberg, A.; Kimball, S. D.; Malley, M.; Moreland, S.; Porubcan, M.; Pudzianowski, A. J. Med. Chem. 1991, 34, 2521.
18. 18 Goldmann, S.; Geiger, W. Angew Chem., Int. Ed. Engl. 1984, 23, 301.
19. 19 Coburn, R. A.; Wierzba, M.; Suto, M. J.; Solo, A. J.; Triggle, A. M.; Triggle, D. J. J. Med. Chem. 1988, 31, 2103.
20. 20 Loev, B.; Snader, K. M. J. Org. Chem. 1965, 30, 1914.
21. 21 Palmer, R. B. Conformational Studies of Dihydropyridine Calcium Channel Antagonists, University of Washington, 1994.
22. 22 Palmer, R. B.; Andersen, N. H. Conformational Dynamics of 4-Aryl-1,4-Dihydropyridine Calcium Channel Antagonists. 2. Computational and Spectroscopic Studies of Possible Dihydropyridine Ring Conformers, Manuscript in Preparation.
23. 23 Gunther, H. NMR Spectroscopy: An Introduction; John Wiley and Sons: New York, 1980; p 243.
24. 24 Andersen, N. H.; Nguyen, K. T.; Eaton, H. L. J. Mag. Reson. 1985, 63, 365.
25. 25 Binsch, G.; Kessler, H. Angew. Chem. Int. Ed. Engl. 1980, 19, 411.
26. 26 Natale, N. R.; Triggle, D. J.; Palmer, R. B.; Lefler, B. J.; Edwards, W. D. J. Med. Chem. 1990, 33, 2255.
27. 27 Dewar, M. J. S.; Zoebisch, E. G.; Healey, E. F.; Stewart, J. J. P. J. Am. Chem. Soc. 1985, 107, 3902.
28. 28 McKenna, J. I., Schlicksupp, L., Natale, N. R., Willett, R. D., Maryanoff, B. E., Flaim, S. F., J. Med. Chem. 1988, 31, 473.
29. 29 Rovnyak, G. C.; Kimball, S. D.; Beyer, B.; Cucinotta, G.; DiMarco, J. D.; Gougoutas, J.; Hedberg, A.; Malley, M.; McCarthy, J. P.; Zhang, R.; Moreland, S. J. Med. Chem. 1995, 38, 119.